$XNCR· SEC filing ·

XNCR Reports $611M Cash, $19.2M Revenue, +12% YoY, Announces $20M Buyback

Xencor, Inc. · PHARMACEUTICAL PREPARATIONS · Now $11.80

-7.5% in 7d after detection

Post-detection moves

1h
1d
+1.2%
3d
+0.1%
7d
-7.5%
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS